Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Responses”

3,967 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,967 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02482376
What this trial is testing

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Duke University 110
Not applicableStudy completedNCT02800317
What this trial is testing

RISAS Procedure in Node Positive Breast Cancer Following NAC

Who this might be right for
Breast NeoplasmNeoadjuvant TherapyAxillary Lymph Nodes+1 more
Erasmus Medical Center 248
Not applicableStudy completedNCT00580086
What this trial is testing

Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Not applicableStudy completedNCT01596790
What this trial is testing

COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Montpellier 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711824
What this trial is testing

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain Metastases, Adult
Colette Shen 41
Early research (Phase 1)WithdrawnNCT05774886
What this trial is testing

Implantable Microdevice for TNBC - Pilot Study

Who this might be right for
Triple Negative Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+4 more
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00595413
What this trial is testing

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

Who this might be right for
Rheumatoid Arthritis
EMD Serono 311
Early research (Phase 1)Study completedNCT00729742
What this trial is testing

Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)

Who this might be right for
Carcinoma, Non-small Cell Lung
Merck Sharp & Dohme LLC 49
Testing effectiveness (Phase 2)Study completedNCT03406468
What this trial is testing

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Maastricht Radiation Oncology 36
Not applicableLooking for participantsNCT06795113
What this trial is testing

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

Who this might be right for
Lymphoma
Ruijin Hospital 4,000
Testing effectiveness (Phase 2)Study completedNCT02103062
What this trial is testing

Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Celgene 41
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Not applicableStudy completedNCT01544686
What this trial is testing

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients

Who this might be right for
Bloodstream Infection
University of Cologne 630
Not applicableUnknownNCT03316469
What this trial is testing

Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS

Who this might be right for
Polycystic Ovary Syndrome
Ain Shams University 40
Not applicableStudy completedNCT01472627
What this trial is testing

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 11
Testing effectiveness (Phase 2)UnknownNCT00979160
What this trial is testing

Evaluation of Response of Dasatinib to Treat Mastocytosis

Who this might be right for
Systemic Mastocytosis
Federico II University 30
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Testing effectiveness (Phase 2)UnknownNCT01887561
What this trial is testing

Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial

Who this might be right for
Myelogenous Leukemia, Chronic, Chronic Phase
Kanto CML Study Group 100
Very early researchActive Not RecruitingNCT05358938
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 22
Next Page